drugset / Trial / NCT00584974
A Safety, Efficacy and Tolerability Study of SEP-225289
RandomizedParallel-groupTriple-blindTreatment
Summary
To determine the safety, efficacy and tolerability of SEP-225289 in subjects with Major Depressive Disorder
Timeline
- Start
- 2007-12
- Primary completion
- 2009-05
- Completion
- 2009-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dasotraline | Small molecule | 0.5 mg | — |
| Subject | Dasotraline | Small molecule | 2 mg | — |
| Comparator | Venlafaxine | Small molecule | 150 mg | — |